References
- André T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, . Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009;27:3109–16. Epub 2009 May 18.
- Gamelin L, Boisdron-Celle M, Delva R, Guérin-Meyer V, Ifrah N, Morel A, . Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: A retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer. Clin Cancer Res 2004;10(12 Pt 1): 4055–61.
- Grothey A, Hart LL, Rowland KM, Ansari RH, Alberts SR, Chowhan NM, . Intermittent oxaliplatin administration and time-to-treatment failure in metastatic colorectal cancer: Final results of the phase III CONcePT trial. J Clin Oncol 2008;26(Suppl):Abstract 4010.
- Cersosimo, RJ. Oxaliplatin-associated neuropathy: A review. Ann Pharmacother 2005;39:128–35.
- Wilson RH, Lehky T, Thomas RR, Quinn MG, Floeter MK, Grem JL. Acute oxaliplatin-induced peripheral nerve hyper-excitability. J Clin Oncol 2002;20:1767–74.
- Grolleau F, Gamelin L, Boisdron-Celle M, Lapied B, Pelhate M, Gamelin E. A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels. J Neurophysiol 2001;85: 2293–7.
- Krapf R, Caduff P, Wagdi P, Staubli M, Hulter HN. Plasma potassium response to acute respiratory alkalosis. Kidney Int 1995;47:217–24.
- Kagiava A, Tsingotjidou A, Emmanouilides C, Theophilidis G. The effects of oxaliplatin, an anticancer drug, on potassium channels of the peripheral myelinated nerve fibres of the adult rat. Neurotoxicology 2008.
- Tan MH, Chay WY, Ng JH, Teh BT, Chew L. Transient bilateral abducens neuropathy with post-tetanic facilitation and acute hypokalemia associated with oxaliplatin: a case report. J Med Case Reports 2009 (in press.)
- Kuwabara S, Kanai K, Sung JY, Ogawara K, Hattori T, Burke D, . Axonal hyperpolarization associated with acute hypokalemia: Multiple excitability measurements as indicators of the membrane potential of human axons. Muscle Nerve 2002;26:283–7.
- Sewell DD, Jeste DV. Metoclopramide–associated tardive dyskinesia: An analysis of 67 cases. Arch Fam Med 1992; 1:271–8.